$MSTRBearishMed

Strategy Wanted to 'Inoculate' the Bitcoin Market—Has Its BTC Sale Backfired?

Bitcoin fell about 10% in early June, from ~$74,000 to ~$65,400, as investors focused on Strategy’s first BTC sale since 2022. In an 8-K, Strategy said it sold 32 BTC (~$2.5M) the prior week, reversing its “never sell” stance. The sale coincided with Strategy retiring $1.5B of 2029 convertibles using $1.38B cash and buying 24,869 BTC, while STRC and MSTR shares declined.

Med
Bearish
after the Monday 8-K disclosure and during the immediate post-sale market repricing
bearish—article highlights BTC drop, liquidations, and STRC depegging tied to dividend/BTC-selling narrative

Near-term downside risk to MSTR tied to perceived dividend-coverage stress and potential follow-on BTC selling.

Strategy’s 8-K disclosed it sold 32 BTC, and the article links the move to MSTR/STRC depegging and investor-confidence shock.

Volatility likely elevated; bias to further downside/underperformance until market digests whether selling is a one-off.

Background

Strategy (Michael Saylor’s Bitcoin treasury firm) has historically marketed a “never sell” Bitcoin stance; the article frames the first post-2022 BTC sale as a potential shift driven by dividend and debt/cash management.

Why it matters

The disclosed BTC sale is presented as the trigger for a rapid risk-off repricing in BTC and in Strategy’s preferred equity (STRC) and common (MSTR), with analysts debating whether this is a one-off timing issue or a structural change to the dividend-funded model.

Market relevance

Material for trading Strategy’s complex (MSTR/STRC) because the article ties a specific 8-K BTC sale to immediate price moves, liquidations, and a debate over whether more selling/equity actions are likely.

Market effects

Read-through for leveraged Bitcoin proxy/treasury models: investors may demand higher risk premia when dividend obligations imply potential BTC sales.

Limited direct regional impact; primarily US-listed crypto-equity sentiment and derivatives positioning.

Global crypto markets react via BTC price and liquidation cascades, with second-order effects from macro risk appetite.

Alternative perspectives

The BTC sale and cash/bond actions may be fundamentally sound balance-sheet management, with depegging viewed as temporary “leverage friction” rather than a death spiral.

Stabilization catalysts mentioned include potential regulatory progress (U.S. Clarity Act) and the possibility that Strategy uses targeted MSTR equity raises and STRC dividend structure changes instead of additional BTC sales.

Key entities

  • Strategy

    Bitcoin treasury firm that sold 32 BTC per an 8-K, reversing its prior “never sell” messaging and raising dividend-coverage concerns.

  • STRC

    Strategy’s preferred perpetual stock that depegged from $100 par to about $94.84 after the BTC sale narrative.

  • MSTR

    Strategy’s common stock, reported down sharply after the BTC sale disclosure and amid the STRC depegging narrative.

  • Michael Saylor

    Chair of Strategy; discussed selling Bitcoin to “inoculate” the market and pay dividends.

Related articles

$NVDAMed

Market Indexes Tumble at Midday as Treasury Yields Spike on Hot Employment Report

U.S. stocks fell after a stronger-than-expected jobs report Friday. By 1:18 p.m. ET, the Nasdaq Composite was down nearly 3%, the S&P 500 fell 1.8%, and the Dow slipped 0.8%, with tech down 4.3% and defensives higher. May nonfarm payrolls rose 172,000 (vs. 86,000 expected) and unemployment held at 4.3%, prompting traders to price a quarter-point rate hike by end-2026.

$MSTRMed

Here's what could happen if bitcoin breaks below $60,000

Bitcoin is trading near $62,300 and is approaching the $60,000 support level, amid record ETF outflows, according to the article. Deribit’s Jean-David Péquignot said institutions bought BTC at $60,000–$67,000, so a break below $60,000 could trigger selling and more liquidations. The report cites $1.2 billion in $60,000 put open interest and “short gamma,” which may mechanically intensify declines.

$MSTRMed

Strategy’s Bitcoin Sale Raises Solvency Concerns As Bitcoin Crashes

Bitcoin fell 21% in 10 days, retesting $61,000, as Strategy (MSTR) paused some buying after using $1.38B cash from recent equity raises to repurchase convertible debt. The company’s cash fell to $900M, covering ~6 months of dividends. Traders cite tighter liquidity and STRC below $100, but Strategy’s 11% net leverage is described as conservative, with no contractual forced liquidation.

$MSTRMed

Strategy’s Bitcoin Model Under Pressure, Grayscale Warns

Grayscale said Strategy’s leveraged Bitcoin model is under pressure, citing Zach Pandl’s warning that Strategy may have limited ability to accumulate BTC at current share prices for STRC and MSTR. Strategy sold 32 BTC on Monday and $128 million of shares; its stock fell 12.8% to $126. Grayscale warned STRC’s discount to par could raise dividend needs and trigger more BTC sales.

$MSTRMed

Strategy’s Bitcoin Sale Raises Solvency Concerns As Bitcoin Crashes

Bitcoin fell 21% in 10 days, retesting $61,000, as Strategy (MSTR) paused some BTC accumulation after using $1.38B of cash from recent equity sales to buy back convertible debt. Cash fell to $900M. The report says Strategy’s 11% net leverage is conservative, reducing forced liquidation risk, but STRC trades below $100 and spot ETF flows are net selling, limiting upside.